Valneva SE (VALN) Free Cash Flow Growth (1y) (2022 - 2026)
Valneva SE (VALN) Free Cash Flow Growth (1y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
60.84% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
88.70% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
-15.72% |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
66.37% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Valneva SE |
167.33 Mn |
44.10 Mn |
5.08 Mn |
98.86% |
| Date | Value |
|---|
| Mar 31, 2026 |
98.86% |
| Dec 31, 2025 |
-120.08% |
| Sep 30, 2025 |
-293.84% |
| Jun 30, 2025 |
96.14% |
| Mar 31, 2025 |
74.24% |
| Dec 31, 2024 |
81.90% |
| Sep 30, 2024 |
-100.01% |
| Jun 30, 2024 |
99.94% |
| Mar 31, 2024 |
-17.65% |
| Dec 31, 2023 |
15.17% |
| Sep 30, 2023 |
76,186.67% |
| Jun 30, 2023 |
-89,973.36% |
| Mar 31, 2023 |
-12.14% |
| Dec 31, 2022 |
18.78% |
| Sep 30, 2022 |
-291.97% |
| Jun 30, 2022 |
-198.23% |
| Mar 31, 2022 |
-125.44% |
